A Process Analytical Technology approach to near-infrared process control of pharmaceutical powder blending. Part I: D-optimal design for characterization of powder mixing and preliminary spectral data evaluation

被引:77
作者
El-Hagrasy, AS
D'Amico, F
Drennen, JK [1 ]
机构
[1] Duquesne Univ Ctr Pharmaceut Technol, Pittsburgh, PA 15282 USA
[2] Bristol Myers Squibb Co, Proc Anal Technol Grp, Pharmaceut Dev Ctr Excellence, Pharmaceut Res Inst, New Brunswick, NJ 08903 USA
[3] Duquesne Univ, Dept Math & Comp Sci, McAnulty Coll & Grad Sch Liberal Arts, Pittsburgh, PA 15282 USA
关键词
Process Analytical Technology (PAT); near-infrared spectroscopy; blend uniformity; particle size; moisture sorption; physical characterization; static charge; experimental design; principal component analysis; multivariate analysis;
D O I
10.1002/jps.20467
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Experimental design, multivariate data acquisition, and analysis in addition to real time monitoring and control through process analyzers, represent an integrated approach for implementation of Process Analytical Technology (PAT) in the pharmaceutical industry. This study, which is the first in a series of three parts, uses an experimental design approach to identify critical factors affecting powder blending. Powder mixtures composed of salicylic acid and lactose were mixed in an 8 qt. V-blender. D-optimal design was employed to characterize the blending process, by studying the effect of humidity, component concentration, and blender speed on mixing end point. Additionally, changes in particle size and density of powder mixtures were examined. A near-infrared (NIR) fiber-optic probe was used to monitor mixing, through multiple optical ports on the blender. Humidity, component concentration, and blender speed were shown to have a significant impact on the blending process. Furthermore, humidity and concentration had a significant effect on particle size and density of powder mixtures. NIRS was sensitive to changes in physicochemical. properties of the mixtures, resulting from process variables. Proper selection of NIR spectral preprocessing is of ultimate importance for successful implementation of this technology in the monitoring and control of powder blending and is discussed. (C) 2005 Wiley-Liss, Inc. and the American Pharmacists Association.
引用
收藏
页码:392 / 406
页数:15
相关论文
共 24 条
[1]  
Abounassif Mohammed A., 1994, V23, P421
[2]   Unit dose sampling: A tale of two thieves [J].
Berman, J ;
Schoeneman, A ;
Shelton, JT .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1996, 22 (11) :1121-1132
[3]   BLEND UNIFORMITY AND UNIT DOSE SAMPLING [J].
BERMAN, J ;
PLANCHARD, JA .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1995, 21 (11) :1257-1283
[4]  
BERMAN J, 1997, 25 PDA, V51, pS1
[5]  
Boehm G, 2003, PDA J PHARM SCI TECH, V57, P64
[6]   Quantitative characterization of mixing of dry powders in V-blenders [J].
Brone, D ;
Alexander, A ;
Muzzio, FJ .
AICHE JOURNAL, 1998, 44 (02) :271-278
[7]   An evaluation of a unit-dose compacting sample thief and a discussion of content uniformity testing and blending validation issues [J].
Chang, RK ;
Shukla, J ;
Buehler, J .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1996, 22 (9-10) :1031-1035
[8]   Near-infrared spectroscopy and imaging for the monitoring of powder blend homogeneity [J].
El-Hagrasy, AS ;
Morris, HR ;
D'Amico, F ;
Lodder, RA ;
Drennen, JK .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (09) :1298-1307
[9]  
ELHAGRASY A, 2002, NIR NEWS, V13, P8
[10]  
FDA, 2004, GUID IND PAT FRAM IN